Targeting LMTK3 in ovarian cancer: A dual role in prognosis and therapy

Targeting LMTK3 in ovarian cancer: A dual role in prognosis and therapy

Saved in:

Bibliographic Details
Main Authors:	Chrysa Filippopoulou, Georgios Giamas
Format:	Article
Language:	English
Published:	Elsevier 2024-12-01
Series:	Molecular Therapy: Oncology
Online Access:	http://www.sciencedirect.com/science/article/pii/S2950329924001449
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Targeted Therapy in Ovarian Cancer
by: Marcus Vetter, et al.
Published: (2021-06-01)

The oncogenic roles of GPR176 in ovarian cancer: a molecular target for aggressiveness and gene therapy
by: Ning Yang, et al.
Published: (2024-12-01)

Immune Response in Ovarian Cancer: How Is the Immune System Involved in Prognosis and Therapy: Potential for Treatment Utilization
by: Nikos G. Gavalas, et al.
Published: (2010-01-01)

Overexpression of Notch3 and pS6 Is Associated with Poor Prognosis in Human Ovarian Epithelial Cancer
by: Zhaoxia Liu, et al.
Published: (2016-01-01)

The impact of homologous recombination deficiency on the prognosis of epithelial ovarian cancer
by: Haiqi Su, et al.
Published: (2025-01-01)

Impact of Underweight after Treatment on Prognosis of Advanced-Stage Ovarian Cancer
by: Se Ik Kim, et al.
Published: (2014-01-01)

Exosome-Associated Gene Signature for Predicting the Prognosis of Ovarian Cancer Patients
by: Zihan Zhu, et al.
Published: (2023-01-01)

Engineered CAF-cancer cell hybrid membrane biomimetic dual-targeted integrated platform for multi-dimensional treatment of ovarian cancer
by: Yuwei Yao, et al.
Published: (2025-02-01)

DGAT1 Expression Promotes Ovarian Cancer Progression and Is Associated with Poor Prognosis
by: Leilei Xia, et al.
Published: (2021-01-01)

Reverse-engineering the FLT3-PI3K/AKT axis to enhance TILs function and improve prognosis in ovarian and cervical cancers
by: Feng Hao, et al.
Published: (2025-01-01)

Editorial: The role of non-coding RNAs in gynecological cancers: new perspectives in cancer therapy and prognosis
by: Stefano Restaino, et al.
Published: (2024-12-01)

Effect of fibroblast heterogeneity on prognosis and drug resistance in high-grade serous ovarian cancer
by: Tingjie Wang, et al.
Published: (2024-11-01)

Dual targeting and bioresponsive nano-PROTAC induced precise and effective lung cancer therapy
by: Xiaoling Guan, et al.
Published: (2024-11-01)

Relationship between programmed cell death and targeted therapy for thyroid cancer in patients with a poor prognosis: an update
by: Yuejia Zhao, et al.
Published: (2025-02-01)

Lemur tail kinase 3 serves as a predictor of patient outcomes and a target for the treatment of ovarian cancer
by: Ghassan M. Saed, et al.
Published: (2024-09-01)

A clinical study of autologous chimeric antigen receptor macrophage targeting mesothelin shows safety in ovarian cancer therapy
by: Xiumin Li, et al.
Published: (2024-11-01)

Identification of Hypoxia Signature to Assess the Tumor Immune Microenvironment and Predict Prognosis in Patients with Ovarian Cancer
by: Chunyan Wei, et al.
Published: (2021-01-01)

Targeting TOP2A in Ovarian Cancer: Biological and Clinical Implications
by: Fulvio Borella, et al.
Published: (2024-12-01)

Potential Target Antigens for a Universal Vaccine in Epithelial Ovarian Cancer
by: Renee Vermeij, et al.
Published: (2010-01-01)

Immunotherapy of Ovarian Cancer: The Role of Checkpoint Inhibitors
by: Francesca De Felice, et al.
Published: (2015-01-01)

Identification and Clinical Validation of High HSP60 Expression Predicts Poor Prognosis in Patients with Ovarian Cancer
by: Zheng M, et al.
Published: (2025-01-01)

Characterization of tumor prognosis and sensitive chemotherapy drugs based on cuproptosis-related gene signature in ovarian cancer
by: Wei Tan, et al.
Published: (2025-01-01)

miR-21 Responsive Nanocarrier Targeting Ovarian Cancer Cells
by: Liting Han, et al.
Published: (2024-12-01)

Promising new drugs and therapeutic approaches for treatment of ovarian cancer—targeting the hallmarks of cancer
by: Julia Hillmann, et al.
Published: (2025-01-01)

Efficacy of PARPi re-maintenance therapy for recurrent ovarian cancer
by: Yulin Wang, et al.
Published: (2025-01-01)

Scoulerine promotes cytotoxicity and attenuates stemness in ovarian cancer by targeting PI3K/AKT/mTOR axis
by: Wang Fang, et al.
Published: (2023-09-01)

A Primer on the Role of TP53 Mutation and Targeted Therapy in Endometrial Cancer
by: Bohao Zhang, et al.
Published: (2025-01-01)

Contribution of m5C RNA Modification-Related Genes to Prognosis and Immunotherapy Prediction in Patients with Ovarian Cancer
by: Yibin Liu, et al.
Published: (2023-01-01)

Integrated multiomics characterization reveals cuproptosis-related hub genes for predicting the prognosis and clinical efficacy of ovarian cancer
by: Yang Xiaorong, et al.
Published: (2024-11-01)

Notch3 and Its Clinical Importance in Ovarian Cancer
by: Bimal Prasad Jit, et al.
Published: (2024-10-01)

The dual edges of neoadjuvant chemotherapy in advanced epithelial ovarian cancer: Therapeutic potential and clinical dilemmas
by: Li Jia, et al.
Published: (2024-12-01)

Singlet Oxygen-Induced Mitochondrial Reset in Cancer: A Novel Approach for Ovarian Cancer Therapy
by: Jorgelindo da Veiga Moreira, et al.
Published: (2024-11-01)

Targeting PARG induces tumor cell growth inhibition and antitumor immune response by reducing phosphorylated STAT3 in ovarian cancer
by: Lorna Rodriguez-Rodriguez, et al.
Published: (2024-04-01)

Causal role of ischemic heart disease in ovarian cancer subtypes
by: Jianhai Chen, et al.
Published: (2025-01-01)

Role of lymphadenectomy in advanced-stage ovarian cancer: a meta-analysis
by: Carlo Ronsini, et al.
Published: (2024-11-01)

Pan-cancer analysis highlights the role of PSENEN in the prognosis and immunology of cancer
by: Zerui YANG, et al.
Published: (2023-03-01)

Identification of immunogenic cell death gene-related subtypes and risk model predicts prognosis and response to immunotherapy in ovarian cancer
by: Wenjing Pan, et al.
Published: (2024-12-01)

Pre-treatment nutrition-related indicators and the prognosis of patients with newly diagnosed epithelial ovarian cancer: an ambispective cohort study
by: Shirui Wang, et al.
Published: (2025-01-01)

Proteomics and Bioinformatics Investigations Link Overexpression of FGF8 and Associated Hub Genes to the Progression of Ovarian Cancer and Poor Prognosis
by: Vikrant Kumar, et al.
Published: (2024-01-01)

Inflammasome-targeted therapy for oral cancer: Highlighting NLRP3 inflammasome as a promising clinical therapeutic target
by: Geetha Shanmugam
Published: (2024-06-01)